Combined inhibition of key potassium currents has different effects on cardiac repolarization reserve and arrhythmia susceptibility in dogs and rabbits by Husti, Zoltán et al.
ARTICLE
Combined inhibition of key potassium currents has different
effects on cardiac repolarization reserve and arrhythmia
susceptibility in dogs and rabbits1
Zoltán Husti, Katalin Tábori, Viktor Juhász, Tibor Hornyik, András Varró, and István Baczkó
Abstract:A reliable assessment of the pro-arrhythmic potential for drugs in the development phase remains elusive. Rabbits and
dogs are commonly used to create models of pro-arrhythmia, but the differences between them with respect to repolarizing
potassium currents are poorly understood. We investigated the incidence of drug-induced torsades de pointes (TdP) and mea-
sured conventional ECG parameters and the short-term variability of the QT interval (STVQT) following combined pharmacolog-
ical inhibition of IK1+IKs and IK1+IKr in conscious dogs and anesthetized rabbits. A high incidence of TdP was observed following
the combined inhibition of IK1+IKs in dogs (67% vs. 14% in rabbits). Rabbits exhibited higher TdP incidence after inhibition of
IK1+IKr (72% vs. 14% in dogs). Increased TdP incidence was associated with signiﬁcantly larger STVQT in bothmodels. The relatively
different roles of IK1 and IKs in dog and rabbit repolarization reserve should be taken into account when extrapolating the results
from animal models of pro-arrhythmia to humans. A stronger repolarization reserve in dogs (likely due to stronger IK1 and IKs),
and the more human-like susceptibility to arrhythmia of rabbits argues for the preferred use of rabbits in the evaluation of
adverse pro-arrhythmic effects.
Key words: cardiac electrophysiology, potassium channels, torsades de pointes, IK1, IKs.
Résumé : L’évaluation ﬁable du potentiel arythmogène des médicaments en développement n’est pas encore a` notre portée. On
utilise fréquemment les lapins et les chiens dans les modèles d’arythmogénicité, mais on ne saisit pas bien les différences qui
existent entre les espèces quant aux courants potassiques repolarisants. Nous avons étudié la fréquence de l’apparition
de torsades de pointes et mesuré les paramètres conventionnels de l’ECG ainsi que la variabilité a` court terme de la durée de
l’intervalle QT (STVQT) a` la suite des associations d’inhibition pharmacologique d’IK1+IKs et d’IK1+IKr chez des chiens a` l’état de
conscience et des lapins sous anesthésie. La fréquence de l’apparition de torsades de pointes était élevée après l’inhibition
associée d’IK1+IKs chez les chiens (67 % vs. 14 % chez les lapins). Par contre, l’apparition de torsades de pointes était plus fréquente
chez les lapins après l’inhibition associée d’IK1+IKr (72 % vs. 14 % chez les chiens). L’augmentation de la fréquence de l’apparition
de torsades de pointes était associée a` une augmentation notable de la STVQT dans les deux modèles. Les rôles relatifs distincts
des courants IK1 et IKs sur la réserve de repolarisation observée chez le chien et le lapin doivent être pris en compte lorsque l’on
extrapole l’interprétation des résultats obtenus avec des modèles animaux d’arythmogénicité en la faisant porter sur l’humain.
Une réserve de repolarisation plus élevée chez le chien (probablement en raison de courants IK1 et IKs plus forts) et une
susceptibilité aux arythmies chez le lapin plus ressemblante a` celle de l’humain plaident pour l’utilisation préférentielle des
lapins en vue d’évaluer les effets indésirables de type arythmogène. [Traduit par la Rédaction]
Mots-clés : électrophysiologie cardiaque, canaux potassiques, torsades de pointes, IK1, IKs.
Introduction
The proper assessment of the pro-arrhythmic potential of
candidate compounds is a major concern for drug development
(Haverkamp et al. 2000) because drug-induced arrhythmias, in-
cluding torsades de pointes (TdP), can lead to sudden cardiac
death (Fenichel et al. 2004). Prediction of TdP in the clinical setting
is very difﬁcult because the incidence of drug-induced TdP is very
low (1:100 000); however, drug-associated sudden cardiac death
has led to thewithdrawal of several compounds in the past. There-
fore, the reliable preclinical assessment of pro-arrhythmic side-
effects is essential. Importantly, current methods mostly concentrate
on testing the hERG blocking and (or) ventricular repolarization
prolonging effects of these compounds, primarily in healthy tis-
sues and animals, and these cardiac safety tests are not sensitive
enough (Food and Drug Administration, HHS 2005a, 2005b; Thomsen
et al. 2006; Farkas and Nattel 2010).
The inhibition of cardiac potassium channels prolongs repolar-
ization and refractoriness, leading to Class III antiarrhythmic
effects (Singh and Vaughan Williams 1970). However, excessive
prolongation of repolarization by Class III antiarrhythmic drugs,
seen as marked QT interval prolongation on the electrocardio-
gram (ECG), can result in drug-induced TdP (Hondeghem and
Snyders 1990; El-Sherif 1992). On the other hand, experimental
and clinical studies have suggested that the degree of repolariza-
tion prolongation does not show a close correlation with subse-
quent ventricular arrhythmia development (vanOpstal et al. 2001;
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Thomsen et al. 2004; Lengyel et al. 2007; Hinterseer et al. 2009,
2010). In these cases, without marked prolongation of the QT
interval, repolarization reserve may be reduced with a conse-
quent increase in arrhythmia susceptibility. According to the con-
cept of repolarization reserve, normal cardiac repolarization is
controlled by different potassium currents in a redundant way,
and congenital or acquired (e.g., mild potassium current inhibi-
tion by a non-cardiovascular drug) decrease in the function of a
single repolarizing current does not always lead to marked pro-
longation of repolarization because other currents can compen-
sate for the lost function (Roden 1998; Varró and Baczkó 2011). In
the case of reduced repolarization reserve, additional inhibition of
another repolarizing current can result in excessive prolongation of
repolarization and provoke serious ventricular arrhythmias.
Experimental evidence from studies on both animal and hu-
man ventricular myocardium point to a critically important role
for the slow component of the delayed rectiﬁer potassium current
(IKs) in ventricular repolarization reserve (Volders et al. 1999, 2003;
Varró et al. 2000; Lengyel et al. 2001, 2007; Jost et al. 2005;
Abi-Gerges et al. 2006). In addition to IKs, other ventricular repo-
larizing potassium currents may signiﬁcantly contribute to repo-
larization reserve, including the transient outward current (Ito)
(Virág et al. 2011) and the inward rectiﬁer current (IK1) (Biliczki
et al. 2002). There is considerable variation in the expression of
key repolarizing potassium channels in differentmammalian spe-
cies (Zicha et al. 2003). The dog and rabbit are frequently used in
various in-vitro and in-vivo models of pro-arrhythmia. Therefore,
it is reasonable to assume that species-speciﬁc ion channel expres-
sion proﬁles may result in species-dependent alterations in re-
sponse to potassium channel blockers (Nerbonne and Kass 2005).
Such differences may signiﬁcantly inﬂuence the value of data
obtained in these models for human extrapolation. Indeed, a re-
cent study found similar densities for the rapid component of the
delayed rectiﬁer current (IKr) and signiﬁcantly lower densities for
IK1 and IKs in human ventricular myocytes compared with their
canine counterparts, suggesting that humans may exhibit a re-
duced repolarization reserve and could bemore susceptible to the
adverse pro-arrhythmic effects of drugs that block IKr (Jost et al.
2013a). However, it is not clear how species-speciﬁc potassium
channel expressions translate into differences in arrhythmia de-
velopment in dogs and rabbits. We have previously shown that
repolarization reserve impairment by pharmacological blocking
of IKs increased susceptibility to arrhythmia to a similar degree
during the subsequent IKr inhibition in dogs and rabbits (Lengyel
et al. 2007).
In this study, we examined the effects of combined pharmaco-
logical inhibition of IK1 and IKs as well as IK1 and IKr on ECG param-
eters and the incidence of TdP in conscious dogs and anesthetized
rabbits. We also investigated whether TdP development was par-
alleled by increased short-term variability of the QT interval; a
novel ECG parameter that is recommended for a more reliable
prediction of drug-induced ventricular arrhythmias.
Materials and methods
Ethical issues
All experiments were carried out in compliance with the Guide
for the Care and Use of Laboratory Animals (ILAR 1996) and the proto-
col was approved by the Ethical Committee for the Protection of
Animals in Research of the University of Szeged, Szeged, Hungary
(approval number I-74-5-2012) and by the Department of Animal
Health and Food Control of the Ministry of Agriculture (authority
approval number XIII/1211/2012).
Conscious dogs
Beagles of either sex, weighing 10–15 kg, were used for the
experiments. The animals were acclimated to the experiment’s
personnel and equipment every day for a week before the start of
the actual experiments. Baseline recordings were obtained after a
20 min equilibration period. The animals were then randomly
assigned to 1 of 2 groups. The dogs in Group 1 (n = 7) were ﬁrst
intravenously (i.v.) administered the IK1 inhibitor BaCl2 (3.0 mg/kg
body mass) followed by the IKr inhibitor dofetilide (25.0 g/kg;
Gedeon Richter, Budapest, Hungary), after a 20 min equilibration
period. The dogs in Group 2 (n = 6) ﬁrst received the IKs inhibitor
HMR 1556 (1.0 mg/kg, i.v.), followed by BaCl2 (3.0 mg/kg, i.v.) after
a 20 min equilibration period. The drugs were administered dur-
ing a 5 min continuous i.v. infusion (Terufusion TE-3; Terumo
Europe, Leuven, Belgium). The ECGwas obtained using precordial
leads andwas digitized and stored on a computer for later analysis
using National Instruments data acquisition hardware (National
Instruments, Austin, Texas, USA) and SPEL Advanced Haemosys
software (version 3.2; Experimetria, Budapest, Hungary; MDE
Heidelberg GmbH, Heidelberg, Germany). The PQ, R–R, and QT
intervals were measured from the mean of 30 consecutive beats
(the minimum number of beats required for the calculation of
beat-to-beat short-term variability of an interval; see below) and
the frequency-corrected QT interval (QTc) was calculated using
the formula recommended speciﬁcally for beagles: QTc  QT 
0.087R–R 1000 (Van deWater et al. 1989; Tattersall et al. 2006).
The intervals weremeasured at the following time points during the
experiments: (i) 2 min before the start of drug infusion (baseline);
(ii) 5 min after the end of the drug infusions; and (iii) at the ECG
sectiondirectly preceding the arrhythmia still in sinus rhythm if TdP
(Fig. 1) or any other ventricular arrhythmias occurred.
Anesthetized rabbits
MaleNewZealandwhite rabbits (2–3 kg) were anesthetizedwith
thiopentone (50 mg/kg, i.v.) delivered into the marginal vein of
the right ear. A catheter ﬁlled with isotonic saline containing
500 IU/mL heparin was inserted into the left carotid artery for the
measurement of arterial blood pressure. The right jugular vein
was cannulated for subsequent i.v. drug administration. The ani-
mals were allowed to stabilize for 20 min and then baseline mea-
surements were taken. Group 1 (n = 7) was administered the IK1
inhibitor BaCl2 (0.3 mg/kg, i.v., in a volume of 2.0 mL/kg during a
5min infusion) followed by the IKr inhibitor dofetilide (25.0g/kg,
i.v.) 20min after BaCl2 administration. Group 2 (n = 7) received the
IKs inhibitor HMR 1556 (0.1 mg/kg, i.v.; Aventis Pharma, Frankfurt
amMain, Germany) followed by BaCl2 (0.3mg/kg, i.v.) 20min after
HMR 1556 administration.
Blood pressure and ECG (leads I, II, and III) were continuously
recorded (at 200 Hz), digitized, and stored on a computer for anal-
ysis using National Instruments data acquisition hardware and
SPEL Advanced Haemosys software. The PQ, R–R, and QT intervals
were measured as the mean of 30 beats (the minimum number of
beats required for the calculation of short-term variability of an
interval; see below). During the measurement of the QT interval
in anaesthetized rabbits, the guidelines described by Farkas et al.
(2004) were followed. In rabbits with a signiﬁcantly faster heart
rate than that of humans, QTc calculated with Bazett’s formula
does not accurately reﬂect the heart-rate-dependent changes in
the QT interval. Accordingly, QTc was calculated using the follow-
ing formula speciﬁcally suggested for anaesthetized rabbits by
Batey and Coker (2002): QTc  QT  0.704R–R  250.
Short-term beat-to-beat variability of the R–R (STVR–R) and
QT intervals (STVQT)
Temporal instability of beat-to-beat heart rate and repolariza-
tion can be quantitatively characterized by the calculation of the
beat-to-beat short-term variability (STV) of the R–R or QT intervals,
respectively. The calculation of STV is based on previously de-
tailed mathematical analysis (Brennan et al. 2001) and was calcu-
lated as follows: STV  |Dn1  Dn|30×2
1, where D is the
duration of the QT or R–R interval. The intervals used in the
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calculation were the result of 30 consecutive interval measure-
ments in sinus rhythm at a given time point during the experi-
ments. In the case of experiments where TdP occurred, the
measurements were taken in sinus rhythm prior to the develop-
ment of TdP. To illustrate temporal instability of the QT interval,
Poincaré plots of the QT intervals were constructed in which each
QT valuewas plotted against its former value (Figs. 3B and 5B). STV
represents themean orthogonal distance to the line-of-identity on
the Poincaré plot.
Compounds
HMR 1556 was dissolved in dimethylsulfoxide (0.1% v/v) to provide
a stock solution of 10.0 mol/L. Dofetilide was dissolved in saline to
provide a stock solution of 5.0 mol/L. BaCl2 was dissolved in
distilled water to provide a stock solution of 100.0 mmol/L. Each
stock solution was diluted immediately before use.
Statistical analysis
The incidence of TdP (%) was compared using a 2 test with
Yates’ correction for continuity. All other data are the mean ± SD.
Data within groups were compared after repeated-measures one-
way analysis of variance (ANOVA) using the Bonferroni post-hoc
test, and we used Student’s t test for pair-wise comparisons of the
groups. Values for p < 0.05 were considered to be statistically
signiﬁcant.
Results
Effect of combined inhibition of IK1 and IKr on R-R and QTc
intervals in conscious dogs and anesthetized rabbits
For both dogs and rabbits, administration of the IK1 inhibitor
BaCl2 alone did not change heart rate or the R–R intervals (Fig. 2A).
However, infusion of the IKr inhibitor dofetilide signiﬁcantly in-
creased R–R intervals (Fig. 2A) and decreased heart rate (dogs:
66.9 ± 16.96 beats/min vs. 80.5 ± 12.12 beats/min in the controls;
rabbits: 213.9 ± 1.92 beats/min vs. 258.6 ± 1.26 beats/min in the
controls; p < 0.05). In a previous study by our group, the IKr inhib-
itor dofetilide administered alone did not alter the R–R interval
but, as expected, signiﬁcantly prolonged the QTc interval in con-
scious dogs and anesthetized rabbits (Lengyel et al. 2007).
In conscious dogs, inhibition of IK1 signiﬁcantly prolonged the
QTc interval, as calculated with the Van deWater formula (Van de
Water et al. 1989), and dofetilide infusion caused a further, signif-
icant prolongation of the QTc interval (Fig. 3A, left panel). The
uncorrected QT intervals yielded similar prolongation: 317.4 ±
47.9 ms after IK1 blockade and 373.5 ± 37.8 ms after combined
inhibition of IK1+IKr, vs. 221.4 ± 11.7 ms in the controls (p < 0.05). In
anesthetized rabbits, only the combined inhibition of IK1+IKr re-
sulted in signiﬁcant QTc interval prolongation (Fig. 3A, right
panel). Again, the uncorrected QT intervals showed a similar pro-
longation, but only after combined inhibition of IK1+IKr (150.6 ±
5.88 ms after inhibition of IK1, and 167.8 ± 6.27 ms after combina-
tion treatment with BaCl2+dofetilide vs. 147.2 ± 5.46 ms in the
controls).
Effect of combined inhibition of IK1 and IKr on the short-
term variability of R–R (STVR–R) and QT intervals (STVQT) in
conscious dogs and anesthetized rabbits
Because heart rate affects the duration of repolarization, the
short-term variability in the R–R intervals was also calculated in
addition to STVQT, which is the ECG parameter recently suggested
for more reliable prediction of ventricular arrhythmias. In con-
scious dogs, STVR–R did not change signiﬁcantly following IK1 and
combined inhibition of IK1+IKr (Fig. 2B, left panel). In anesthetized
rabbits, the combination of BaCl2+dofetilide slightly, but signiﬁ-
Fig. 1. Representative torsades de pointes recordings from (A) a conscious dog following combined inhibition of IKs+IK1, and (B) an
anesthetized rabbit following the combined inhibition of IK1+IKr.
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cantly, increased STVR–R; however, the magnitude of these changes
(< 0.5ms)makes it very unlikely that this STVR–R changemarkedly
inﬂuenced repolarization variability (Fig. 2B, right panel). The IKr
inhibitor dofetilide administered alone did not alter STVR–R in
conscious dogs and anesthetized rabbits in our previous study
(Lengyel et al. 2007).
The Poincaré plots in Fig. 3B illustrate the temporal instability
of repolarization in 2 individual animals: a conscious dog (left
panel), and an anesthetized rabbit (right panel), following inhibi-
tion of IK1 and combined inhibition of IK1+IKr. Both animals exhib-
ited TdP arrhythmia as a result of the combined treatment with
BaCl2+dofetilide, and the scatter of data points covering a large
area on the plot following this combination treatment represents
large STVQT values in these animals (15.8 ms in the dog and 4.9 ms
in the rabbit). Grouped STVQT data showed a signiﬁcant increase
in both species following combined inhibition of IK1+IKr (Fig. 3C).
Dofetilide alone did not increase STVQT in conscious dogs; how-
ever, in our previous study, it signiﬁcantly increased STVQT in
anesthetized rabbits (Lengyel et al. 2007).
Effect from combined inhibition of IKs+IK1 on R–R and QTc
intervals in conscious dogs and anesthetized rabbits
The IKs inhibitor HMR 1556 did not change the R–R interval
signiﬁcantly in conscious dogs or anesthetized rabbits, and this
result was in agreement with our previous observations (Lengyel
et al. 2007). However, the combined inhibition of IKs+IK1 caused a
signiﬁcant increase in R–R intervals and a decrease in heart rate in
rabbits only (Fig. 4A, right panel).
In conscious dogs, inhibition of IKs signiﬁcantly increased the
QTc interval, similar to our previous observations in conscious
dogs (Lengyel et al. 2007). In these animals, subsequent infusion of
BaCl2 caused a further, signiﬁcant QTc prolongation (Fig. 5A, left
panel). The uncorrected QT intervals showed similar prolonga-
tion: 317.5 ± 35.2 ms after IKs blockade and 387.4 ± 45.4 ms after
combined inhibition of IKs+IK1, vs. 230.5 ± 7.6 ms in the controls
(p < 0.05). In anesthetized rabbits, inhibition of IKs did not alter
QTc, and combined inhibition of IKs+IK1 only had a slight tendency
to increase QTc, but this change did not prove to be statistically
signiﬁcant (Fig. 5A, right panel).
Effect from combined inhibition of IKs and IK1 on the
short-term variability in R–R (STVR–R) and QT (STVQT)
intervals in conscious dogs and anesthetized rabbits
HMR 1556 did not alter STVR–R in conscious dogs or anesthetized
rabbits. The combined inhibition of IKs+IK1 again caused a signiﬁ-
cant, but very small (<1 ms) increase in STVR-R in anesthetized
rabbits (Fig. 4B, right panel).
The Poincaré plots in Fig. 5B illustrate repolarization temporal
instability in 2 individual animals, a conscious dog (left panel) and
an anesthetized rabbit (right panel), following inhibition of IKs
and combined inhibition of IKs+IK1. The shift in QT interval data,
pointing to the right and upward direction in the conscious dog,
Fig. 2. Effects from the inhibition of IK1 (i.v. BaCl2) and combined inhibition of IK1+IKr (i.v. BaCl2+dofetilide) on (A) R–R interval, and (B) short-
term variability of the R–R interval (STVR-R) in conscious dogs and anesthetized rabbits; n = 7 dogs or 7 rabbits/group; *, p < 0.05 compared
with the control values; #, p < 0.05 compared with inhibition of IK1.
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represent the previously described QT prolongation following
HMR 1556 administration. Careful observation of the plot reveals
that in this animal (that later developed TdP after combined inhi-
bition of IKs+IK1), the QT variability only increased after combina-
tion treatment with HMR 1556+BaCl2 (Fig. 5B, left panel). In
accordance with the grouped STVQT data represented in Fig. 5C
(right panel) for the representative rabbit in Fig. 5B, STVQT did not
increase signiﬁcantly after treatment with HMR 1556 or combina-
tion treatment with HMR 1556+BaCl2 in anesthetized rabbits. In
contrast, in conscious dogs this combination treatment led to a
signiﬁcant increase in STVQT (Fig. 2E, left panel). Importantly, in
parallel to this STVQT increase, conscious dogs responded to com-
bined inhibition of IKs+IK1 with signiﬁcantly increased TdP inci-
dence, whereas only 1 of 7 rabbits developed TdP following this
combined inhibition, and the grouped data for the rabbits did not
show elevated STVQT (Fig. 5C).
Effect from combined inhibition of IK1+IKr, and IKs+IK1 on
the incidence of TdP in conscious dogs and anesthetized
rabbits
As shown in Figs. 6A and 6B, inhibition of IK1 or IKs alone did not
provoke TdP in any of the animals.Wehave previously shown that
the IKr inhibitor dofetilide alone did not cause TdP in conscious
dogs but did cause TdP in 25% of the anesthetized rabbits (Lengyel
et al. 2007). Combined inhibition of repolarizing currents, how-
ever, led to a signiﬁcant number of TdP episodes in both species,
albeit in a different manner.
Interestingly, conscious dogs and anesthetized rabbits exhib-
ited different TdP incidence following the combined inhibition of
key potassium currents: a signiﬁcant number of conscious dogs
developed TdP following combined inhibition of IKs+IK1, whereas
only one rabbit developed TdP. On the other hand, TdP incidence
increased signiﬁcantly following combined inhibition of IK1+IKr in
Fig. 3. Effect from the inhibition of IK1 (i.v. BaCl2) and combined inhibition of IK1+IKr (i.v. BaCl2+dofetilide) inhibition on (A) frequency-corrected QT
interval (QTc) and (B and C) short-term variability of the QT interval (STVQT) in conscious dogs and anesthetized rabbits. For details on the Poincaré
plot (B) see text; n = 7 dogs or 7 rabbits/group; *, p < 0.05 compared with the control values; #, p < 0.05 compared with inhibition of IK1.
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rabbits, whereas only one dog exhibited TdP following combina-
tion treatment with BaCl2+dofetilide (Figs. 6A and 6B).
Discussion
Dog and rabbit are animals frequently used for studying proar-
rhythmia, and we have previously established a model of proar-
rhythmia based on repolarization reserve impairment achieved
by pharmacological inhibition of IKs, a key potassium current in
repolarization reserve (Lengyel et al. 2007). Recently, other potas-
sium channels were also implicated in repolarization reserve, in-
cluding IK1 (for a recent review see Varró and Baczkó 2011). Species
differences exist in the expression of important ion channels car-
rying repolarizing current (Zicha et al. 2003), most likely leading
to species-speciﬁc differences in repolarization reserve and in re-
sponses to compounds with even mild potassium channel inhib-
itory properties (Nerbonne and Kass 2005). Therefore, further
characterization of the roles different potassium currents play in
canine and rabbit pro-arrhythmia models are needed to assist in
the proper extrapolation of data obtained in these models to hu-
man subjects.
In this study, we investigated the effects of repolarization
reserve impairment by pharmacological inhibition of IK1 in com-
bination with IKs and IKr on the incidence of the typical drug-
induced arrhythmia, TdP, and different ECG parameters in an
experimental setup similar to that used in our previous study in
which the effects of the combined pharmacological inhibition of
IKs and IKr were characterized in conscious dogs and anesthetized
rabbits (Lengyel et al. 2007). We have shown that combined phar-
macological inhibition of other potassium currents leads to repo-
larization reserve impairment and a high incidence of TdP in
conscious dogs and anesthetized rabbits. However, dogs and rab-
bits exhibited markedly different patterns of TdP development in
response to combined inhibition of IK1+IKr and IKs+IK1, suggesting
that at least some of these currents may play relatively different
roles in repolarization reserve in these animals. In contrast, we
have previously shown that both animals responded with a high
incidence of TdP, paralleled by signiﬁcant increases in short-term
variability of the QT interval, irrespective of the sequence in
which the inhibitors of IKs and IKr were administered (Lengyel
et al. 2007).
The key role of IKs in ventricular repolarization reserve is well-
established in different animals/species and in humans (Volders
et al. 1999, 2003; Varró et al. 2000; Lengyel et al. 2001, 2007; Jost
et al. 2005, 2007; Abi-Gerges et al. 2006; Johnson et al. 2010). How-
ever, a recent study highlighted that because of lower IKs densities
in human hearts, repolarization reserve may be reduced in hu-
mans by comparison with dogs (Jost et al. 2013a). Attributed to
low-level IKs beta-subunit minK expression, a low IKs current den-
sity and increased TdP susceptibility were described in rabbits (Lu
et al. 2001; Zicha et al. 2003). In a recent comparative study, the
kinetics of rabbit IKs were found to bemore human-like compared
with IKs in guinea pigs and dogs (Jost et al. 2013b). These data
indicate that despite the relatively well-characterized role of IKs in
repolarization reserve, the signiﬁcant differences described in IKs
Fig. 4. Effect from the inhibition of IKs (i.v. HMR 1556) and combined inhibition of IKs+IK1 (i.v. HMR 1556+BaCl2) inhibition on (A) R–R interval
and (B) short-term variability of the R–R interval (STVR-R) in conscious dogs and anesthetized rabbits; n = 6 dogs or 7 rabbits/group; *, p < 0.05
compared with the control values; #, p < 0.05 compared with inhibition of IKs.
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subunit expression, current densities, and kinetics in rabbits and
dogs make extrapolation of the results to humans somewhat dif-
ﬁcult.
The roles other repolarizing potassium currents may play in
repolarization reserve are poorly understood. Among these repo-
larizing potassium currents, possible roles for Ito (Virág et al. 2011)
and IK1 (Biliczki et al. 2002; Varró and Baczkó 2011) in repolari-
zation reserve have been suggested. In LQT7 (Andersen–Tawil
syndrome), loss of function mutations in Kir2.1 channels may
signiﬁcantly decrease IK1 current; however, the substantially in-
creased pro-arrhythmic risk in these patients is not accompanied
by marked QTc prolongation on the ECG (Zhang et al. 2005). Com-
puter modelling studies also support a key role for IK1 in ventri-
cles: in these models, reduction of IK1 in addition to IKr blockade
led to early after-depolarizations (Ishihara et al. 2009). A variety of
channel subtypes can be responsible for the IK1 current, including
alpha-subunits Kir2.1, Kir2.2, Kir2.3, and Kir2.4 (for a recent
review see Anumonwo and Lopatin 2010). Signiﬁcant species-
speciﬁc differences in the expression of Kir2.x proteins have
been previously reported (Wang et al. 1998; Melnyk et al. 2002;
Dhamoon and Jalife 2005). Different heteromeric assembly of
Kir2.x proteins leads to different IK1 characteristics (Dhamoon
et al. 2004) and, most likely, to altered overall cardiac electrophys-
iological responses to drugs. A heteromeric assembly of Kir2.1 and
Kir2.2 was reported in rabbit cardiomyocytes (Zobel et al. 2003). In
dogs, Kir2.2 and Kir2.4 levels were minimal, whereas in humans,
Kir2.3mRNA expressionwas on a similar level to Kir2.1, and Kir2.1
mRNA expression was 3 times higher in dogs compared with hu-
mans (Jost et al. 2013a).
Based on the abovementioned studies, and also supported by
the results from this study, because of stronger IK1 and IKs in dogs
by comparison with rabbits and humans, dogs may exhibit larger
Fig. 5. Effect from inhibition of IKs (i.v. HMR 1556) and combined inhibition of IKs+IK1 (i.v. HMR 1556+BaCl2) on (A) frequency-corrected QT interval
(QTc) and (B and C) short-term variability of the QT interval (STVQT) in conscious dogs and anesthetized rabbits. For details on the Poincaré plot (B)
see text; n = 6 dogs or 7 rabbits/group; *, p < 0.05 compared with the control values; #, p < 0.05 compared with the inhibition of IKs.
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repolarization reserve. Therefore, rabbit pro-arrhythmia models
based on pharmacologically impaired repolarization reserve may
represent greater arrhythmia susceptibility andmay bemore use-
ful than canine models in predicting human electrophysiological
responses to drugs affecting cardiac ventricular repolarization.
In this study, the short-term variability in the QT interval was
calculated to assess the temporal instability of repolarization fol-
lowing pharmacological inhibition of repolarizing potassium cur-
rents. The STVQT characterizes differences in the QT intervals of
consecutive heart beats, and has been suggested as amore reliable
measure of pro-arrhythmic risk associated with impaired repolar-
ization reserve compared with conventional ECG parameters of
repolarization (Berger 2003; Varkevisser et al. 2012). In this regard,
a number of previous in vivo and in vitro experimental and clin-
ical animal studies (van Opstal et al. 2001; Thomsen et al. 2004;
Lengyel et al. 2007; Hinterseer et al. 2009, 2010) found that STVQT
was increased and showed a better correlation with subsequent
arrhythmias than QT prolongation in animals or individuals with
decreased repolarization reserve later exhibiting serious ventric-
ular arrhythmias. In this study we found that combined inhibi-
tion of IK1+IKr and IKs+IK1 led to increased STVQT in parallel with
increased incidence of TdP in most cases, further supporting the
role of STVQT determination in ventricular arrhythmia risk esti-
mation. It should be noted that we found a signiﬁcant increase in
STVQT in the dogs after combined inhibition of IK1+IKr inhibition,
with only one animal showing TdP; however, very short episodes
of nonsustained monomorphic ventricular tachycardia were ob-
served in 3 additional animals.
In conclusion, both rabbits and dogs are susceptible to pharma-
cological impairment of repolarization reserve and concomitant
ventricular arrhythmia induction by compounds that inhibit re-
polarizing currents. This study has further conﬁrmed that STVQT
may be a better predictor of subsequent drug-induced TdP devel-
opment than conventional ECG parameters characterizing repo-
larization prolongation. Importantly, however, rabbits are more
susceptible to combined inhibition of IK1+IKr than dogs, and dogs
are more susceptible to combined inhibition of IK1+IKs than rab-
bits, suggesting different relative roles for IK1 and IKs in repolar-
ization reserve for these animals. These results warrant cautious
evaluation of the potentially adverse pro-arrhythmic effects and
cardiovascular safety of candidate compounds in rabbit and dog
models. The different relative roles of repolarizing potassium cur-
rents in these species need to be considered when extrapolating
rabbit and canine pro-arrhythmia study results to humans.
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